NCT04493554View on ClinicalTrials.gov

The Effects of Vasopressin on Attention Control

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

January 1, 2021

Conditions
Healthy
Interventions
DRUG

Vasopressin

Administration of vasopressin (20 IU) intranasally

DRUG

Placebo

Administration of placebo intranasally

Trial Locations (1)

611731

University of Electronic Science and Technology of China(UESTC), Chengdu

All Listed Sponsors
lead

University of Electronic Science and Technology of China

OTHER

NCT04493554 - The Effects of Vasopressin on Attention Control | Biotech Hunter | Biotech Hunter